Profil
Olesya Didenko served as the President, CEO, CFO, Secretary & Treasurer of Enumeral Biomedical Holdings, Inc. from 2012 to 2014.
She obtained an undergraduate degree from Baikal State University of Economics & Law.
Ehemalige bekannte Positionen von Olesya Didenko
Unternehmen | Position | Ende |
---|---|---|
ENUMERAL BIOMEDICAL HOLDINGS INC | Vorstandsvorsitzender | 04.08.2014 |
Ausbildung von Olesya Didenko
Baikal State University of Economics & Law | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Enumeral Biomedical Holdings, Inc.
Enumeral Biomedical Holdings, Inc. BiotechnologyHealth Technology Enumeral Biomedical Holdings, Inc. is a biopharmaceutical company, which engages in the business of discovering and developing novel antibody immunotherapies for the treatment of cancer and other diseases. It also focuses on the development of a pipeline of next generation monoclonal antibody drugs targeting established and novel immuno-modulatory receptors. The company was founded by Barry C. Buckland, John J. Rydzewski, and Arthur H. Tinkelenberg on December 11, 2009 and is headquartered in Arlington, MA. | Health Technology |